| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |